History | Social, emotional and mental wellbeing in primary and secondary education | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Equality and health inequalities assessment

Equality impact assessment (PDF 296 KB)

Published:

06 July 2022

Consultation comments published

Consultation comments and responses (PDF 4.96 MB)

Published:

06 July 2022

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 429 KB)

Published:

14 January 2022
Evidence review A (PDF 6.59 MB)

Published:

14 January 2022
Evidence review B (PDF 14.77 MB)

Published:

14 January 2022
Evidence review C (PDF 2.19 MB)

Published:

14 January 2022
Evidence review D (PDF 5.59 MB)

Published:

14 January 2022
Evidence review E (PDF 809 KB)

Published:

14 January 2022
Evidence review F (PDF 837 KB)

Published:

14 January 2022
Evidence review G (PDF 3.75 MB)

Published:

14 January 2022
Evidence review H (PDF 5.98 MB)

Published:

14 January 2022
Evidence review I (PDF 5.15 MB)

Published:

14 January 2022
Evidence review J (PDF 1.65 MB)

Published:

14 January 2022
Economic report - Tool (Excel 3.05 MB)

Published:

14 January 2022
Supporting documentation - Methods (PDF 385 KB)

Published:

14 January 2022
Supporting documentation - CYP Report (PDF 3.59 MB)

Published:

14 January 2022
Equality impact assessment 3 (PDF 125 KB)

Published:

14 January 2022
Comments form (MSWord 44 KB)

Published:

14 January 2022
Addendum appendix Acknowledgements (PDF 214 KB)

Published:

07 February 2023

Stakeholder list updated

Stakeholder list (PDF 175 KB)

Published:

06 July 2022

Committee list updated

Committee member list (PDF 136 KB)

Published:

13 January 2022

Declaration of interests

Register of interests (PDF 1.12 MB)

Published:

07 February 2023

Pre-consultation documents released

Economic plan (PDF 153 KB)

Published:

03 November 2021
Review questions (PDF 179 KB)

Published:

03 November 2021
Search strategies (PDF 3.22 MB)

Published:

03 November 2021

Committee meetings

Committee meeting
Minutes 0 (PDF 206 KB)

Published:

10 September 2019
Minutes 1 (PDF 189 KB)

Published:

31 October 2019
Minutes 2 (PDF 168 KB)

Published:

01 November 2019
Minutes 3 (PDF 206 KB)

Published:

16 December 2019
Minutes 4 (PDF 180 KB)

Published:

09 March 2020
Minutes 5 (PDF 219 KB)

Published:

06 October 2020
Minutes 6 & 7 (PDF 219 KB)

Published:

14 December 2020
Minutes 8 (PDF 188 KB)

Published:

29 January 2021
Minutes 9 (PDF 201 KB)

Published:

01 February 2021
Minutes 10 (PDF 147 KB)

Published:

26 February 2021
Minutes 11 (PDF 149 KB)

Published:

13 April 2021
Minutes 12 (PDF 158 KB)

Published:

14 April 2021
Minutes 13 (PDF 190 KB)

Published:

09 June 2021
Minutes 14 (PDF 156 KB)

Published:

10 June 2021
Minutes 15 (PDF 187 KB)

Published:

16 August 2021
Minutes 16 (PDF 169 KB)

Published:

08 October 2021
Minutes 17 (PDF 222 KB)

Published:

24 September 2021
Minutes 18 (PDF 208 KB)

Published:

29 March 2022
Minutes 19 (PDF 176 KB)

Published:

18 March 2022
Minutes 20 (PDF 198 KB)

Published:

20 April 2022

Scope published

Final scope (PDF 277 KB)

Published:

31 July 2019
Consultation comments and responses (PDF 1.49 MB)

Published:

31 July 2019
Equality impact assessment 2 (PDF 155 KB)

Published:

31 July 2019

Draft scope consultation

Draft scope consultation
Comments form (MSWord 66 KB)

Published:

26 April 2019
Equality impact assessment 1 (PDF 170 KB)

Published:

26 April 2019
Draft scope (PDF 349 KB)

Published:

26 April 2019

Scoping workshop: London

Workshop notes (PDF 175 KB)

Published:

26 April 2019